期刊文献+

缺氧与糖、脂肪代谢在类风湿关节炎发病中的作用 被引量:3

Role of hypoxia, glucose metabolism and fat metabolism in pathogenesis of rheumatoid arthritis: an update
下载PDF
导出
摘要 类风湿关节炎(rheumatoid arthritis,RA)是一种以关节滑膜慢性炎症为主要特征的自身免疫性疾病。该病致病机制不明,长期以来,RA发病机制的研究集中在炎症及免疫反应方面。近年研究发现,代谢与免疫密切相关。缺氧及糖、脂肪的代谢异常可影响免疫细胞的发育、分化和功能,从而导致自身免疫性疾病的发生。近年来,越来越多的研究关注代谢途径在免疫和RA发病中的作用,以期从不同的角度探讨RA的发病机制并为RA的治疗提供新的思路。本文复习了近年来相关文献,回顾缺氧及糖、脂肪代谢在免疫和RA发病中的作用。 Rheumatoid arthritis(RA)is an autoimmune disease characterized by chronic synovial membrane inflammation.The pathogenesis of RA is unknown,and the related researches mainly focus on inflammation and immune response.Recent researches have found that metabolism is closely related to immunity.Besides,hypoxia and metabolic disorders of glucose and fat can also affect the development,differentiation and function of immune cells,and then lead to occurrence of autoimmune diseases.In recent years,more and more studies have focused on the role of metabolic pathways in the immunity and pathogenesis of RA,in order to explore the pathogenesis of RA from different perspectives and to provide new ideas for the treatment of RA.In this review,we summarized the role of hypoxia,glucose metabolism and fat metabolism in immunity and pathogenesis of RA.
作者 李婷 殷健 徐沪济 LI Ting;YIN Jian;XU Huji(Department of Rheumatology and Immunology,Changzheng Hospital,Navy Medical University(Second Military Medical University),Shanghai 200003,China)
出处 《第二军医大学学报》 CAS CSCD 北大核心 2018年第3期297-301,共5页 Academic Journal of Second Military Medical University
关键词 类风湿关节炎 缺氧 葡萄糖代谢 脂肪代谢 炎症 免疫反应 rheumatoid arthritis hypoxia glucose metabolism lipometabolism inflammation immunological reaction
  • 相关文献

参考文献1

二级参考文献17

  • 1成虎.难治性类风湿关节炎38例治疗观察[J].中国社区医师(医学专业),2007,9(9):85-85. 被引量:2
  • 2Numohamed MT, Dijkmans BA. Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and bio- logic agents in rheumatoid arthritis. Drugs, 2005, 65: 661-694.
  • 3Van der Heijden JW, Dijkmans BA, Scheper RJ, et al. Drug insight: resistance to methotrexate and other disease-modifying antirheumatic drugs-from bench to bedside. Nat Clin Pract Rheumatol, 2007, 3: 26-34.
  • 4Mittal N, Mittal R, Sharma A, et al. Treatment failure withdisease-modifying antirheumatic drugs in rheumatoid arthritis patients. Singapore Med J, 2012, 53: 532-536.
  • 5Loo TW, Bartlett MC, Clarke DM, et al. Disulfide cross-linking analysis shows that transmembrane segments 5 and 8 of hu- man P-glycoprotein are close together on the cytoplasmic side of the membrane. J Biol Chem, 2004, 279: 7692-7697.
  • 6Lindqvist E, Saxne T, Geborek P, et al. Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage. Ann Rheum Dis, 2002, 61 : 1055- 1059.
  • 7Morgan C, Lunt M, Brightwell H, et al. Contribution of patient related differences to multidrug resistance in rheumatoid arthritis. Ann Rheum Dis, 2003, 62: 15-19.
  • 8Agarwal V, Mittal SK, Misra R. Expression of muhidrug re- sistance-1 protein correlates with disease activity rather than the refractoriness to methotrexate therapy in rheumatoid arthritis. Clin Rheumatol, 2009, 28: 427-433.
  • 9Tsujimura S, Saito K, Nawata M, et al. Overcoming drug re- sistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis. Ann Rheum Dis, 2008, 67: 380-388.
  • 10Tsujimura S, Saito K, Nakayamada S, et al. Etanercept over- comes P-glycoprotein-induced drug resistance in lymphocytes of patients with intractable rheumatoid arthritis. Mod Rheumatol, 2010, 202: 139-146.

共引文献5

同被引文献29

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部